1. Home
  2. LRE vs VVOS Comparison

LRE vs VVOS Comparison

Compare LRE & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LRE
  • VVOS
  • Stock Information
  • Founded
  • LRE 2001
  • VVOS 2016
  • Country
  • LRE Japan
  • VVOS United States
  • Employees
  • LRE N/A
  • VVOS N/A
  • Industry
  • LRE
  • VVOS Medical Specialities
  • Sector
  • LRE
  • VVOS Health Care
  • Exchange
  • LRE Nasdaq
  • VVOS Nasdaq
  • Market Cap
  • LRE 20.5M
  • VVOS 19.4M
  • IPO Year
  • LRE 2023
  • VVOS 2020
  • Fundamental
  • Price
  • LRE $1.33
  • VVOS $2.42
  • Analyst Decision
  • LRE
  • VVOS Strong Buy
  • Analyst Count
  • LRE 0
  • VVOS 3
  • Target Price
  • LRE N/A
  • VVOS $6.50
  • AVG Volume (30 Days)
  • LRE 115.8K
  • VVOS 137.1K
  • Earning Date
  • LRE 07-30-2015
  • VVOS 11-17-2025
  • Dividend Yield
  • LRE N/A
  • VVOS N/A
  • EPS Growth
  • LRE N/A
  • VVOS N/A
  • EPS
  • LRE N/A
  • VVOS N/A
  • Revenue
  • LRE $110,330,328.00
  • VVOS $14,393,000.00
  • Revenue This Year
  • LRE N/A
  • VVOS $19.45
  • Revenue Next Year
  • LRE N/A
  • VVOS $70.80
  • P/E Ratio
  • LRE N/A
  • VVOS N/A
  • Revenue Growth
  • LRE 3.92
  • VVOS 2.65
  • 52 Week Low
  • LRE $1.00
  • VVOS $1.98
  • 52 Week High
  • LRE $2.97
  • VVOS $7.95
  • Technical
  • Relative Strength Index (RSI)
  • LRE 43.40
  • VVOS 40.11
  • Support Level
  • LRE $1.32
  • VVOS $2.30
  • Resistance Level
  • LRE $1.83
  • VVOS $2.48
  • Average True Range (ATR)
  • LRE 0.16
  • VVOS 0.16
  • MACD
  • LRE -0.03
  • VVOS 0.02
  • Stochastic Oscillator
  • LRE 19.70
  • VVOS 33.33

About LRE Lead Real Estate Co. Ltd

Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment building units to individual customers in Japan and Dallas, Texas. Predominantly, its revenue is generated from developing and selling single-family homes and condominiums. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

Share on Social Networks: